Jana de Boniface

27PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOral and maxillofacial surgeryOncology and carcinogenesis not elsewhere classifiedImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 04, 2026
Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

|Jan 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Nov 05, 2025
Omission of Chest-Wall Irradiation after Mastectomy for Breast Cancer.

Jana de Boniface

|Sep 18, 2025
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.

Thorsten Kühn, Maggie Banys-Paluchowski, Nina Ditsch

|Sep 18, 2025
BJS commission on the surgical management of the axilla in breast cancer.

Michael R Boland, Oreste D Gentilini, G Bruce Mann

|Jun 06, 2025
Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trial.

Yvette Andersson, Leif Bergkvist, Lisa Rydén

Pageof 5

Frequent Collaborators

6 joint publications

Oreste Gentilini

5 joint publications

Thorsten Kühn

4 joint publications

Steffi Hartmann

4 joint publications

Laura Niinikoski